The Syntheses of Quinazoline Intermediate of ?Blocker
碩士 === 國立中正大學 === 化學工程所 === 93 === 2-Amino-4-chloro-6,7-dimethoxyquinazoline is a common key intermediate of some a-blocker anti-hypertension drugs including Prazosin, Doxazosin, and Terazosin. The preparation of 2-amino-4-chloro-6,7-dimethoxyquinazoline was first reported by Pfizer pharmaceutical...
Main Authors: | Mei Ling, 傅美玲 |
---|---|
Other Authors: | none |
Format: | Others |
Language: | zh-TW |
Published: |
2005
|
Online Access: | http://ndltd.ncl.edu.tw/handle/72691939932174536183 |
Similar Items
-
Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives
by: Hatem A. Abuelizz, et al.
Published: (2017-06-01) -
Quinazoline
by: Wu, Uong bin, et al.
Published: (1997) -
Synthesis of Triazole-Substituted Quinazoline Hybrids for Anticancer Activity and a Lead Compound as the EGFR Blocker and ROS Inducer Agent
by: Biswadip Banerji, et al.
Published: (2018-11-01) -
Quinazoline derivatives inhibition the effectiveness of the Japanese encephalitis virus
by: Chen-Hsiang Fu, et al.
Published: (2015) -
Effects of DC-015, a newly synthesized quinazoline derivative, on hypertension and platelet aggregation
by: Peng, I-Hsuen, et al.
Published: (1994)